90 related articles for article (PubMed ID: 7906981)
1. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.
Breuer B; De Vivo I; Luo JC; Smith S; Pincus MR; Tatum AH; Daucher J; Minick CR; Miller DG; Nowak EJ
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):63-6. PubMed ID: 7906981
[TBL] [Abstract][Full Text] [Related]
2. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
4. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
Streckfus C; Bigler L; Dellinger T; Dai X; Kingman A; Thigpen JT
Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
[TBL] [Abstract][Full Text] [Related]
5. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma.
Pavelic ZP; Pavelic L; Lower EE; Gapany M; Gapany S; Barker EA; Preisler HD
Cancer Res; 1992 May; 52(9):2597-602. PubMed ID: 1348967
[TBL] [Abstract][Full Text] [Related]
6. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.
Mansour OA; Zekri AR; Harvey J; Teramoto Y; el-Ahmady O
Anticancer Res; 1997; 17(4B):3101-6. PubMed ID: 9329611
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
8. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
Spandidos DA; Field JK; Agnantis NJ; Evan GI; Moore JP
Anticancer Res; 1989; 9(4):821-6. PubMed ID: 2683996
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis.
Molina R; Jo J; Filella X; Zanon G; Pahisa J; Muñoz M; Farrus B; Latre ML; Gimenez N; Hage M; Estape J; Ballesta AM
Anticancer Res; 1996; 16(4B):2295-300. PubMed ID: 8694559
[TBL] [Abstract][Full Text] [Related]
11. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
Meenakshi A; Kumar RS; Kumar NS
J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
[TBL] [Abstract][Full Text] [Related]
12. Serum c-erbB-2 protein in breast cancer patients.
Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
[TBL] [Abstract][Full Text] [Related]
14. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
[TBL] [Abstract][Full Text] [Related]
15. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
16. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer.
Chariyalertsak S; Chariyalertsak S; Cheirsilpa A; Sugano K; Ohkura H
J Med Assoc Thai; 1996 Nov; 79(11):715-21. PubMed ID: 8997010
[TBL] [Abstract][Full Text] [Related]
18. [Development of sandwich radioimmunometric assay for serum c-erbB-2 oncogene product and its significance in diagnosing breast carcinoma].
Yu FZ; Sugano K; Ohkura H; Mori S
Rinsho Byori; 1991 Oct; 39(10):1087-92. PubMed ID: 1684826
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
[TBL] [Abstract][Full Text] [Related]
20. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
